Research progress of proteomics in congenital craniofacial anomalies

Congenital craniofacial anomalies (CFAs) are among the most common birth defects, significantly affecting the appearance, oral function and mental health of patients. These anomalies are etiologically complex, involving genetics, environmental factors and gene-environment interactions. While genetic studies have identified numerous potential causal genes/risk loci for CFAs, the pathogenic mechanisms still largely remain elusive. Proteomics, the large-scale analysis of proteins, offers a comprehensive view of disease pathogenesis and their systemic effects. During the past two decades, the application of proteomics in CFA research has uncovered many biomarkers for early diagnosis and shed light on underlying mechanisms driving these anomalies. Here, we review the advancements and contributions of proteomics to congenital CFA research, outlining technological advances, novel findings from human body fluid proteomics, and integrative multi-omics approaches.

Craniofacial anomaly; Proteomics; Mass spectrometry; Human body fluid proteomics; Research progress

[1] Twigg SR, Wilkie AO. New insights into craniofacial malformations. Human Molecular Genetics. 2015; 24: R50–R59.

[2] de Oliveira Júnior AG, Montagna E, Zaia V, Barbosa CP, Bianco B. Oral health-related quality of life in patients aged 8 to 19 years with cleft lip and palate: a systematic review and meta-analysis. BMC Oral Health. 2023; 23: 670.

[3] Alvizi L, Nani D, Brito LA, Kobayashi GS, Passos-Bueno MR, Mayor R. Neural crest e-cadherin loss drives cleft lip/palate by epigenetic modulation via pro-inflammatory gene-environment interaction. Nature Communications. 2023; 14: 2868.

[4] Zhao H, He Q, Wu X, Liang X, Jiao Y, Zhang Y, et al. Identification of rare loss-of-function variants in FAM3B associated with non-syndromic orofacial clefts. Genomics. 2023; 115: 110630.

[5] Bishop MR, Diaz Perez KK, Sun M, Ho S, Chopra P, Mukhopadhyay N, et al. Genome-wide enrichment of de novo coding mutations in orofacial cleft trios. The American Journal of Human Genetics. 2020; 107: 124–136.

[6] Huang W, Zhong W, He Q, Xu Y, Lin J, Ding Y, et al. Time-series expression profiles of mRNAs and lncRNAs during mammalian palatogenesis. Oral Diseases. 2023; 29: 2163–2176.

[7] Chen X, Xu Y, Li C, Lu X, Fu Y, Huang Q, et al. Key genes identified in nonsyndromic microtia by the analysis of transcriptomics and proteomics. ACS Omega. 2022; 7: 16917–16927.

[8] Dong W, Jiang H, He L, Pan B, Yang Q. Changes in the transcriptome and proteome of cartilage in microtia. Journal of Craniofacial Surgery. 2021; 32: 2301–2304.

[9] Lansdon LA, Dickinson A, Arlis S, Liu H, Hlas A, Hahn A, et al. Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes. The American Journal of Human Genetics. 2023; 110: 71–91.

[10] Awotoye W, Mossey PA, Hetmanski JB, Gowans LJJ, Eshete MA, Adeyemo WL, et al. Whole-genome sequencing reveals de-novo mutations associated with nonsyndromic cleft lip/palate. Scientific Reports. 2022; 12: 11743.

[11] Ray D, Venkataraghavan S, Zhang W, Leslie EJ, Hetmanski JB, Weinberg SM, et al. Pleiotropy method reveals genetic overlap between orofacial clefts at multiple novel loci from GWAS of multi-ethnic trios. PLOS Genet. 2021; 17: e1009584.

[12] Zhao H, Zhong W, Leng C, Zhang J, Zhang M, Huang W, et al. A novel PTCH1 mutation underlies nonsyndromic cleft lip and/or palate in a Han Chinese family. Oral Diseases. 2018; 24: 1318–1325.

[13] Gao Y, Hong Y, Huang L, Zheng S, Zhang H, Wang S, et al. Β2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function. Cell. 2023; 186: 1026.e20–1038.e20.

[14] Jiang L, Wang M, Lin S, Jian R, Li X, Chan J, et al. A quantitative proteome map of the human body. Cell. 2020; 183: 269–283.

[15] Zhang J, Zhou S, Zhang Q, Feng S, Chen Y, Zheng H, et al. Proteomic Analysis of RBP4/vitamin a in children with cleft lip and/or palate. Journal of Dental Research. 2014; 93: 547–552.

[16] Heike CL, Wallace E, Speltz ML, Siebold B, Werler MM, Hing AV, et al. Characterizing facial features in individuals with craniofacial microsomia: a systematic approach for clinical research. Birth Defects Research Part A: Clinical and Molecular Teratology. 2016; 106: 915–926.

[17] Alam MK, Alfawzan AA, Abutayyem H, Kanwal B, Alswairki HJ, Verma S, et al. Craniofacial characteristics in Crouzon’s syndrome: a systematic review and meta-analysis. Science Progress. 2023; 106: 003685042311562.

[18] Deatherage J, Bourgeois T, O’Brien M, Baylis AL. Examining risk of speech-language disorders in children with cleft lip. Journal of Craniofacial Surgery. 2022; 33: 395–399.

[19] Collett BR, Wallace ER, Kapp-Simon KA, Johns AL, Drake AF, Heike CL, et al. Cognitive, motor, and language development of preschool children with craniofacial microsomia. The Cleft Palate-Craniofacial Journal. 2021; 58: 1169–1177.

[20] Chkadua TZ, Libin PV, Sufiomarov NS. Surgical treatment of a patient with mandibular micrognathia accompanied by obstructive sleep apnea syndrome using extended genioplasty. Stomatologiya. 2023; 102: 48.

[21] Whitaker LA, Pashayan H, Reichman J. A proposed new classification of craniofacial anomalies. The Cleft Palate Journal. 1981; 18: 161–176.

[22] Buchanan EP, Xue AS, Hollier LH. Craniofacial syndromes. Plastic and Reconstructive Surgery. 2014; 134: 128e–153e.

[23] Xue AS, Buchanan EP, Hollier LH. Update in management of craniosynostosis. Plastic & Reconstructive Surgery. 2022; 149: 1209e–1223e.

[24] Darjazini Nahas L, Hmadieh M, Audeh M, Yousfan A, Almasri IA, Martini N. Cleft lip and palate risk factors among otorhinolaryngology: head and neck surgery patients in two hospitals. Medicine. 2023; 102: e34419.

[25] Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, et al. Mutations in IRF6 cause van der woude and popliteal pterygium syndromes. Nat Genet. 2002; 32: 285–289.

[26] das Neves LT, de Carvalho IMM, Cobourne MT, Gomide MR. Dental anomalies in non‐syndromic orofacial clefts: a clinical approach. Oral Diseases. 2022; 28: 1351–1368.

[27] Auslander A, McKean-Cowdin R, Feigelson D, Brindopke F, DiBona M, Magee K, et al. The international family study of nonsyndromic orofacial clefts: design and methods. The Cleft Palate-Craniofacial Journal. 2022; 59: S37–S47.

[28] Saleem K, Zaib T, Sun W, Fu S. Assessment of candidate genes and genetic heterogeneity in human non syndromic orofacial clefts specifically non syndromic cleft lip with or without palate. Heliyon. 2019; 5: e03019.

[29] Ronde EM, Nolte JW, Kruisinga FH, Maas SM, Lapid O, Ebbens FA, et al. Evaluating international diagnostic, screening, and monitoring practices for craniofacial microsomia and microtia: a survey study. The Cleft Palate Craniofacial Journal. 2023; 60: 1118–1127.

[30] Petrin AL, Zeng E, Thomas MA, Moretti-Ferreira D, Marazita ML, Xie XJ, et al. DNA methylation differences in monozygotic twins with Van der Woude syndrome. Frontiers in Dental Medicine. 2023; 4: 1120948.

[31] Lau MCC, Kwong EML, Lai KP, Li J, Ho JCH, Chan T, et al. Pathogenesis of POLR1C-dependent type 3 Treacher Collins syndrome revealed by a zebrafish model. Biochimica Et Biophysica Acta (BBA)—Molecular Basis of Disease. 2016; 1862: 1147–1158.

[32] Haaland ØA, Lie RT, Romanowska J, Gjerdevik M, Gjessing HK, Jugessur A. A genome—wide search for gene—environment effects in isolated cleft lip with or without cleft palate triads points to an interaction between maternal periconceptional vitamin use and variants in ESRRG. Frontiers in Genetics. 2018; 9: 60.

[33] Yu Y, Zhen Q, Chen W, Yu Y, Li Z, Wang Y, et al. Genome—wide meta—analyses identify five new risk loci for nonsyndromic orofacial clefts in the Chinese Han population. Molecular Genetics & Genomic Medicine. 2023; 11: e2226.

[34] Dąbrowska J, Biedziak B, Szponar-Żurowska A, Budner M, Jagodziński PP, Płoski R, et al. Identification of novel susceptibility genes for non-syndromic cleft lip with or without cleft palate using NGS-based multigene panel testing. Molecular Genetics and Genomics. 2022; 297: 1315–1327.

[35] Leslie E, Taub M, Liu H, Steinberg K, Koboldt D, Zhang Q, et al. Identification of functional variants for cleft lip with or without cleft palate in or near PAX7, FGFR2, and NOG by targeted sequencing of GWAS loci. The American Journal of Human Genetics. 2015; 96: 397–411.

[36] Yan F, Dai Y, Iwata J, Zhao Z, Jia P. An integrative, genomic, transcriptomic and network-assisted study to identify genes associated with human cleft lip with or without cleft palate. BMC Medical Genomics. 2020; 13: 39.

[37] Messner CB, Demichev V, Muenzner J, Aulakh SK, Barthel N, Röhl A, et al. The proteomic landscape of genome-wide genetic perturbations. Cell. 2023; 186: 2018e.21–2034.e21.

[38] Li Y, Ma C, Liao S, Qi S, Meng S, Cai W, et al. Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus. Frontiers in Immunology. 2022; 13: 969509.

[39] Coscia F, Doll S, Bech JM, Schweizer L, Mund A, Lengyel E, et al. A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis. The Journal of Pathology. 2020; 251: 100–112.

[40] Miltner N, Kalló G, Csősz É, Miczi M, Nagy T, Mahdi M, et al. Identification of SARS-CoV-2 main protease (Mpro) cleavage sites using two-dimensional electrophoresis and in silico cleavage site prediction. International Journal of Molecular Sciences. 2023; 24: 3236.

[41] Yuan X, Liu L, Pu Y, Zhang X, He X, Fu Y. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces a proteomic pattern that defines cleft palate formation in mice. Food and Chemical Toxicology. 2012; 50: 2270–2274.

[42] Chromy BA, Gonzales AD, Perkins J, Choi MW, Corzett MH, Chang BC, et al. Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. Journal of Proteome Research. 2004; 3: 1120–1127.

[43] Swietlik JJ, Sinha A, Meissner F. Dissecting intercellular signaling with mass spectrometry-based proteomics. Current Opinion in Cell Biology. 2020; 63: 20–30.

[44] Sosa‐Acosta P, Melani RD, Quiñones-Vega M, Melo A, Garcez PP, Nogueira FCS, et al. Proteomics of ZIKV infected amniotic fluids of microcephalic fetuses reveals extracellular matrix and immune system dysregulation. Proteomics—Clinical Applications. 2022; 16: e2100041.

[45] Ntai I, Toby TK, LeDuc RD, Kelleher NL. A method for label-free, differential top-down proteomics. Methods in Molecular Biology. 2016; 80: 121–133.

[46] Guo Y, Yu D, Cupp-Sutton KA, Liu X, Wu S. Optimization of protein-level tandem mass tag (TMT) labeling conditions in complex samples with top-down proteomics. Analytica Chimica Acta. 2022; 1221: 340037.

[47] Quiñones‐Vega M, Velásquez E, Sosa‐Acosta P, Melo A, Garcez PP, Nogueira FCS, et al. Proteomic profiles of Zika virus-infected placentas bearing fetuses with microcephaly. Proteomics—Clinical Applications. 2022; 16: e2100042.

[48] Wang C, Zhai S, Yuan X, Zhang D, Jiang H, Qiu L, et al. Common differentially expressed proteins were found in mouse cleft palate models induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoic acid. Environmental Toxicology and Pharmacology. 2019; 72: 103270.

[49] Hou Y, Xu Y, Fu D, Ren Z, Tao Y, Zhao H. Quantitative proteomic analysis of nonsyndromic orofacial cleft patient serum. Oral Diseases. 2023; 29: 206–210.

[50] Jia S, Zhang Q, Wang Y, Wang Y, Liu D, He Y, et al. PIWI-interacting RNA sequencing profiles in maternal plasma-derived exosomes reveal novel non-invasive prenatal biomarkers for the early diagnosis of nonsyndromic cleft lip and palate. EBioMedicine. 2021; 65: 103253.

[51] Nagalla SR, Canick JA, Jacob T, Schneider KA, Reddy AP, Thomas A, et al. Proteomic analysis of maternal serum in down syndrome:  identification of novel protein biomarkers. Journal of Proteome Research. 2007; 6: 1245–1257.

[52] Sutcliffe MJ, Burgoyne PS. Analysis of the testes of H-Y negative XOSxrb mice suggests that the spermatogenesis gene (Spy) acts during the differentiation of the A spermatogonia. Development. 1989; 107: 373–380.

[53] Wang X, Yang X, Huang P, Meng X, Bian Z, Meng L. Identification of maternal serum biomarkers for prenatal diagnosis of nonsyndromic orofacial clefts. Annals of the New York Academy of Sciences. 2022; 1510: 167–179.

[54] Yu B, Zhang B, Wang J, Wang QW, Huang RP, Yang YQ, et al. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum. Experimental Biology and Medicine. 2012; 237: 530–539.

[55] Zuanazzi D, Arts EJ, Jorge PK, Mulyar Y, Gibson R, Xiao Y, et al. Postnatal identification of zika virus peptides from saliva. Journal of Dental Research. 2017; 96: 1078–1084.

[56] Szabo GT, Tihanyi R, Csulak F, Jambor E, Bona A, Szabo G, et al. Comparative salivary proteomics of cleft palate patients. The Cleft Palate-Craniofacial Journal. 2012; 49: 519–523.

[57] Cho CJ, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from down syndrome pregnancies for biomarker discovery. Journal of Proteome Research. 2010; 9: 3574–3582.

[58] Datta S, Turner D, Singh R, Ruest LB, Pierce WM, Knudsen TB. Fetal alcohol syndrome (FAS) in C57BL/6 mice detected through proteomics screening of the amniotic fluid. Birth Defects Research Part A: Clinical and Molecular Teratology. 2008; 82: 177–186.

[59] Tsangaris GT, Karamessinis P, Kolialexi A, Garbis SD, Antsaklis A, Mavrou A, et al. Proteomic analysis of amniotic fluid in pregnancies with down syndrome. Proteomics. 2006; 6: 4410–4419.

[60] Grassia V, Lombardi A, Kawasaki H, Ferri C, Perillo L, Mosca L, et al. Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine. Oncotarget. 2018; 9: 18929–18938.

[61] Rabe A, Gesell Salazar M, Völker U. Bottom-up community proteome analysis of saliva samples and tongue swabs by data-dependent acquisition nano LC-MS/MS mass spectrometry. Methods in Molecular Biology. 2021; 16: 221–238.

[62] Gebara N, Scheel J, Skovronova R, Grange C, Marozio L, Gupta S, et al. Single extracellular vesicle analysis in human amniotic fluid shows evidence of phenotype alterations in preeclampsia. Journal of Extracellular Vesicles. 2022; 11: e12217.

[63] Bhatti G, Romero R, Gomez-Lopez N, Chaiworapongsa T, Jung E, Gotsch F, et al. The amniotic fluid proteome changes with gestational age in normal pregnancy: a cross-sectional study. Scientific Reports. 2022; 12: 601.

[64] Sachs L, Serr DM, Danon M. Prenatal diagnosis of sex using cells from the amniotic fluid. Science. 1956; 123: 548.

[65] Darbinian N, Darbinyan A, Sinard J, Tatevosian G, Merabova N, D’Amico F, et al. Molecular markers in maternal blood exosomes allow early detection of fetal alcohol spectrum disorders. International Journal of Molecular Sciences. 2022; 24: 135.

[66] Schmitt K, Curlin JZ, Remling-Mulder L, Aboellail T, Akkina R. Zika virus induced microcephaly and aberrant hematopoietic cell differentiation modeled in novel neonatal humanized mice. Frontiers in Immunology. 2023; 14: 1060959.

[67] Pang H, Jiang Y, Li J, Wang Y, Nie M, Xiao N, et al. Aberrant NAD+ metabolism underlies Zika virus-induced microcephaly. Nature Metabolism. 2021; 3: 1109–1124.

[68] Tingaud-Sequeira A, Trimouille A, Salaria M, Stapleton R, Claverol S, Plaisant C, et al. A recurrent missense variant in EYA3 gene is associated with oculo-auriculo-vertebral spectrum. Human Genetics. 2021; 140: 933–944.

[69] Riedhammer KM, Burgemeister AL, Cantagrel V, Amiel J, Siquier-Pernet K, Boddaert N, et al. Suleiman-El-Hattab syndrome: a histone modification disorder caused by TASP1 deficiency. Human Molecular Genetics. 2022; 31: 3083–3094.

[70] Kato K, Miya F, Oka Y, Mizuno S, Saitoh S. A novel missense variant in CUL3 shows altered binding ability to BTB-adaptor proteins leading to diverse phenotypes of CUL3-related disorders. Journal of Human Genetics. 2021; 66: 491–498.

[71] Magini P, Smits DJ, Vandervore L, Schot R, Columbaro M, Kasteleijn E, et al. Loss of SMPD4 Causes a Developmental Disorder Characterized by Microcephaly and Congenital Arthrogryposis. American Journal of Human Genetics. 2019; 105: 689–705.

[72] Reilly L, Seddighi S, Singleton AB, Cookson MR, Ward ME, Qi YA. Variant biomarker discovery using mass spectrometry-based proteogenomics. Frontiers in Aging. 2023; 4: 1191993.

[73] Révész Á, Hevér H, Steckel A, Schlosser G, Szabó D, Vékey K, et al. Collision energies: optimization strategies for bottom‐up proteomics. Mass Spectrometry Reviews. 2023; 42: 1261–1299.

[74] Zhou M, Lantz C, Brown KA, Ge Y, Paša-Tolić L, Loo JA, et al. Higher-order structural characterisation of native proteins and complexes by top-down mass spectrometry. Chemical Science. 2020; 11: 12918–12936.

[75] Chen B, Brown KA, Lin Z, Ge Y. Top-down proteomics: ready for prime time? Analytical Chemistry. 2018; 90: 110–127.

[76] Messner CB, Demichev V, Bloomfield N, Yu JSL, White M, Kreidl M, et al. Ultra-fast proteomics with Scanning SWATH. Nature Biotechnology. 2021; 39: 846–854.

[77] Schoof EM, Furtwängler B, Üresin N, Rapin N, Savickas S, Gentil C, et al. Quantitative single-cell proteomics as a tool to characterize cellular hierarchies. Nature Communications. 2021; 12: 3341.

[78] Cong Y, Motamedchaboki K, Misal SA, Liang Y, Guise AJ, Truong T, et al. Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell. Chemical Science. 2020; 12: 1001–1006.

[79] Brunner A, Thielert M, Vasilopoulou C, Ammar C, Coscia F, Mund A, et al. Ultra-high sensitivity mass spectrometry quantifies single‐cell proteome changes upon perturbation. Molecular Systems Biology. 2022; 18: e10798.

[80] Mahdessian D, Cesnik AJ, Gnann C, Danielsson F, Stenström L, Arif M, et al. Spatiotemporal dissection of the cell cycle with single-cell proteogenomics. Nature. 2021; 590: 649–654.

[81] Mund A, Coscia F, Kriston A, Hollandi R, Kovács F, Brunner A, et al. Deep visual proteomics defines single-cell identity and heterogeneity. Nature Biotechnology. 2022; 40: 1231–1240.

[82] Bhatia HS, Brunner AD, Öztürk F, Kapoor S, Rong Z, Mai H, et al. Spatial proteomics in three-dimensional intact specimens. Cell. 2022; 185: 5040–5058.